Daniel Hoft

Title: The Innovative Contributions of Daniel Hoft

Introduction

Daniel Hoft is a prominent inventor based in St. Louis, MO (US), known for his significant contributions to the field of immunology. With a total of three patents to his name, he has made strides in developing vaccines and therapeutic methods for various diseases, including influenza and Chagas disease.

Latest Patents

One of his latest patents is focused on "Peptides for inducing heterosubtypic influenza T cell responses." This invention provides compositions and methods for generating an anti-influenza immune response. It identifies conserved T cell epitopes within matrix protein and nucleoprotein components of the influenza virus, which are screened for their ability to bind to HLA I and II molecules. The patent also describes methods for vaccinating subjects with formulations of these peptides to treat or prevent influenza infection. Another notable patent is "Peptides for inducing Chagas disease responses," which relates to vaccine formulations aimed at treating and preventing Chagas Disease.

Career Highlights

Throughout his career, Daniel Hoft has worked with esteemed institutions such as Saint Louis University and Epivax, Inc. His research has focused on innovative approaches to vaccine development, contributing to advancements in public health.

Collaborations

Daniel has collaborated with notable individuals in his field, including Annie De Groot and Christopher S. Eickhoff. These partnerships have further enhanced his research and the impact of his inventions.

Conclusion

Daniel Hoft's work exemplifies the importance of innovation in the medical field, particularly in vaccine development. His patents and collaborations reflect a commitment to improving health outcomes through scientific research and invention.